-
Merck
-
Hartford, Connecticut
...
Job Description
Role Summary:
The Associate Director for Oncology Strategic ... external strategic alliances and partnerships. The Associate Director, Oncology Strategic Partnerships and
...
-
Merck
-
Hartford, Connecticut
...
Scientific Director (AKA Medical Science Liaison / MSL) | in Inflammatory Bowel Disease Immunology that can ... Regional Medical Scientific Director (Medical Science Liaison) is a credentialed (i.e., PhD, PharmD, DNP
...
-
Merck
-
Hartford, Connecticut
...
Director:
Integrated Delivery Network (IDN, including hospital outpatient and home-infusion if IDN ...
Clinical:
Communicate to customers the clinical value proposition for assigned products using
...
-
Merck
-
Hartford, Connecticut
...
Job Description
Grow and accelerate your career with our Oncology Sales organization and ... continue to grow and define the oncology market of today and tomorrow with a driven, customer-focused, and
...
-
Merck
-
Hartford, Connecticut
...
Job Description
Director – Pharmacometrics, **Quantitative ... an opportunity for the Director to drive pipeline impact and mentor/coach a talented group of
...
-
Merck
-
Hartford, Connecticut
...
Job Description
The US CA Veterinary Insights and Medical Affairs Director sets the ... . The Veterinary Insights and Medical Affairs Director leads a best-in-class team by establishing a
...
-
Merck
-
Hartford, Connecticut
...
the Director, Strategic Account Veterinarian. This position supports the clinical and technical needs ... discuss new products, educate on our medical and technological differentiators, and serve as a problem
...
-
Merck
-
Hartford, Connecticut
...
opportunity for the Associate Director to drive pipeline impact across therapy areas.
This Associate Director will work with scientists within QP2 by applying one or more of the following pharmacometrics
...
-
Merck
-
Hartford, Connecticut
...
Pharmacometrics –** Immune/Oncology (QP2-IO) team in the role of Associate Director QP2-IO team is ... related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration
...